Celularity Inc.

NASDAQ:CELU

1.96 (USD) • At close June 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Revenue 54.2222.77117.97521.33514.27821.14717.554
Cost of Revenue 14.98916.0162.3533.5284.9326.3246.555
Gross Profit 45.3276.755-1.6911.6829.34614.82310.999
Gross Profit Ratio 0.8360.297-0.0940.5480.6550.7010.627
Reseach & Development Expenses 17.38630.46578.36381.72852.707029.063
General & Administrative Expenses 050.53265.85871.08930.5720.5640
Selling & Marketing Expenses 00.0440.1630.252000
SG&A 58.64350.57666.02171.34131.3361.6840.001
Other Expenses 7.656118.001-120.47403.3940-31.604
Operating Expenses 77.589199.04223.91159.694161.27100.001
Operating Income -38.358-192.287-25.6-109.059-151.925-0.564-0.001
Operating Income Ratio -0.707-8.444-1.424-5.112-10.64-0.027-0
Total Other Income Expenses Net -19.534-3.99839.8058.961-61.0087.1110
Income Before Tax -57.892-196.28514.205-100.098-212.9336.547-0.001
Income Before Tax Ratio -1.068-8.620.79-4.692-14.9130.31-0
Income Tax Expense 00.010.0130.02-4.70.66821.302
Net Income -57.892-196.29514.192-100.118-208.2335.879-0.001
Net Income Ratio -1.068-8.620.79-4.693-14.5840.278-0
EPS -2.64-11.021.01-14.9-22.672.460
EPS Diluted -2.64-11.020.95-14.9-172.460
EBITDA -43.706-183.94623.582-88.11-202.405-1.684-0.001
EBITDA Ratio -0.806-8.0781.312-4.13-14.176-0.08-0